BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25701368)

  • 1. Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny.
    Kapoor H; Agrawal DK; Mittal SK
    Transl Res; 2015 Jul; 166(1):28-40. PubMed ID: 25701368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
    Zhang W; Wang DH
    Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
    Souza RF
    J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in understanding the pathogenesis of Barrett's esophagus.
    Clemons NJ; Koh SY; Phillips WA
    Discov Med; 2014 Jan; 17(91):7-14. PubMed ID: 24411696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Barrett's esophagus free of dysplasia.
    DeMeester SR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):279-84. PubMed ID: 9263346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus. Comparison of benign and malignant cases.
    Skinner DB; Walther BC; Riddell RH; Schmidt H; Iascone C; DeMeester TR
    Ann Surg; 1983 Oct; 198(4):554-65. PubMed ID: 6625723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
    Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
    Sato T; Miwa K; Sahara H; Segawa M; Hattori T
    Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF; Krishnan K; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence.
    DeMeester TR
    Surg Oncol; 2001 Nov; 10(3):91-102. PubMed ID: 11750228
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular mechanisms of Barrett's esophagus development.
    Barbera M; Fitzgerald RC
    Surg Oncol Clin N Am; 2009 Jul; 18(3):393-410. PubMed ID: 19500732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.